Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Operating Leases (2022 - 2026)

Bluejay Diagnostics' Operating Leases history spans 2 years, with the latest figure at $189987.0 for Q4 2023.

  • On a quarterly basis, Operating Leases fell 41.35% to $189987.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $189987.0, a 41.35% decrease, with the full-year FY2023 number at $189987.0, down 41.35% from a year prior.
  • Operating Leases hit $189987.0 in Q4 2023 for Bluejay Diagnostics, down from $220093.0 in the prior quarter.
  • Over the last five years, Operating Leases for BJDX hit a ceiling of $601647.0 in Q2 2022 and a floor of $189987.0 in Q4 2023.